From February 29, 2024 to March 31, 2024, the company has repurchased 2,681,558 shares, for CNY 61.3 million. With this, the company has completed the repurchase of 2,681,558 shares, for CNY 61.3 million under the buyback announced on February 29, 2024.
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd
Equities
301130
CNE1000058C4
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
26.9 CNY | +2.48% | +6.58% | -3.52% |
1st Jan change | Capi. | |
---|---|---|
-3.52% | 284M | |
+32.95% | 700B | |
+26.51% | 569B | |
-4.97% | 358B | |
+18.83% | 330B | |
+3.54% | 287B | |
+15.70% | 236B | |
+6.68% | 202B | |
-9.08% | 197B | |
+6.70% | 161B |
- Stock Market
- Equities
- 301130 Stock
- News Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd
- Tranche Update on Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd's Equity Buyback Plan announced on February 29, 2024.